secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLASE, INC (—)
CIK:        0000811240
Form:       8-K
Filed at:   2024-03-05T23:59:59+00:00
Accession:  0001193125-24-058505
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BIOLASE receives Nasdaq deficiency notice for bid price below $1.00
-------------------------------------------------------------------

- On March 4, 2024, Nasdaq notified BIOLASE that its common stock closing bid price was below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until September 3, 2024, to regain compliance by achieving $1.00 close for at least 10 consecutive business days.
- If not cured by Compliance Date, may be eligible for additional 180 days if other listing standards met and a reverse stock split effected.
- Company previously received deficiency notices for stockholders' equity and market value, but was granted extension and recently found compliant on Rule 5550(b)(1).
- Company intends to monitor bid price and consider available options, including a reverse stock split if necessary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811240/000119312524058505/0001193125-24-058505-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811240/000119312524058505/d802491d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-058505

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer